Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brenton Karl Ahrens currently holds 7,246 shares of Iterum Therapeutics plc (ITRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brenton Karl Ahrens has been a net seller of ITRM stock. They have purchased $11.6M and sold $23.9M worth of shares.
Brenton Karl Ahrens's most recent insider trade was on Sep 20, 2022, when they sold 7,246 shares at $1.78 per share.
Brenton Karl Ahrens serves as Executive at Iterum Therapeutics plc (ITRM). They have executed 24 insider transactions totaling $35.5M over their tenure at the company.
Brenton Karl Ahrens holds the position of Executive at Iterum Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Brenton Karl Ahrens has shown a selling trading pattern, with $11.6M in total purchases and $23.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brenton Karl Ahrens was on May 31, 2011, when they sold $20.6M worth of ACTV shares. This transaction involved 1,371,701 shares at $15.00 per share.
Brenton Karl Ahrens currently owns 7,246 shares of Iterum Therapeutics plc (ITRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brenton Karl Ahrens's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brenton Karl Ahrens has 24 Form 4 filings on record as an insider at Iterum Therapeutics plc.
Set alerts for Brenton Karl Ahrens and 40,000+ other insiders.